Developer docs
API playgroundTry for free, no card

Search company profiles

Nexentria

Full company profile

uuid00099fu

Namestring
Nexentria
Legal namestring
Nexentria Inc.
Websiteurl
nexentria.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Nexentria Inc. is a privately-held SaaS company founded in 2023 and headquartered in San Francisco that sells an AI-powered Medical Information (MI) management platform to pharmaceutical and life sciences organizations. The platform unifies MI inquiry handling, Adverse Event (AE) and Product Quality Complaint (PQC) intake, AI-assisted content creation, real-time analytics, and integrated telephony across five modular products that customers can adopt individually or as a full end-to-end suite. Core technical components include an AI Co-Pilot using natural language processing for inquiry triage and response drafting, a generative AI engine that produces compliant Standard Response Documents (SRDs) and summaries, a Compliance Co-Pilot that flags content risk before distribution, AI autodetection for safety and quality events, and integrated telephony with call recording and transcription. The product is built for omni-channel intake, version-controlled content lifecycle management, multilingual support, and 360-degree audit readiness, with claimed GDPR, ISO 9001, ISO 27001, and HIPAA compliance.

The company targets three primary customer segments: small-to-mid-size life science brands, large pharmaceutical brands, and Contract Research Organizations (CROs) serving multiple sponsors. Its go-to-market is an enterprise field sales motion with quote-based modular pricing, multi-year SaaS contracts, and a demo-driven conversion funnel; pricing is not publicly disclosed. Distribution is direct (no channel partners disclosed) and the platform is positioned to integrate with customers' existing CRM, pharmacovigilance, and regulatory systems. Only one customer is publicly named — Biomapas, a global CRO — and the platform is described as capable of scaling from 5 to 50,000 inquiries per week. The company is led by co-founders Vilius Fokas (CEO, formerly at Biomapas and Avon), Stavros Tsompanidis (CPO, formerly at BMS, BioNTech and Intercept Pharmaceuticals), and Maksim Yankovskiy (CTO, formerly at Siemens Medical Solutions, Acuson and Zettaset SafeNet/Thales). No funding rounds, revenue figures, or institutional investors are disclosed in the available source material.

Short descriptiontext

Nexentria sells a modular, AI-powered Medical Information management SaaS platform to pharmaceutical brands and CROs, unifying MI inquiry handling, adverse event and product quality complaint intake, generative AI content creation, analytics, and integrated telephony with built-in regulatory compliance.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical information management, pharmaceutical AI platform, adverse event intake, generative AI content, integrated telephony solutions
Industry3 codes
PRIMARYHLACAEAJ
Adherence, Reminders & Engagement Automation (Medication/Follow-up)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms
SECONDARYHDAAAGAJ
B2B SaaS & Enterprise Personalization (CRM, Sales, Support)
SECONDARYBPAFAFAI
Customer Engagement & Messaging (Email, SMS, Push, In-App)
NAICS code2 codes
  • Software Publishers5132
  • Software Publishers513210
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Pharmaceutical Medical Information Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Subscription
TypeSubscription Recurring
Description

Modular SaaS platform with subscription-based pricing. Customers can purchase individual modules (MI Inquiry Management, AI Content Creation, Real-Time Analytics, Integrated Telephony, Unified AE/PQC Intake) or the full platform. Flexible pricing allows starting with one module and scaling to all-in-one platform

nexentria.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details1 tier
1Modular pricing - start with single module or full platform
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Start with one module or go all-in with the full platform. Scale at your own pace, expanding when ready. No public pricing listed - quote-based enterprise sales model.

nexentria.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Nexentria sells a modular, AI-powered Medical Information (MI) SaaS platform for pharmaceutical brands and Contract Research Organizations (CROs). The platform combines an AI Co-Pilot, generative AI content creation, integrated telephony, unified AE/PQC intake, and real-time analytics to capture, triage and resolve medical information inquiries, adverse events, and product quality complaints at scale. Customers can license individual modules or scale to the full end-to-end platform under multi-year, quote-based enterprise agreements.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 2x faster onboarding compared to industry standard
+1 more record
Product overview1 text field

Nexentria offers an AI-powered Medical Information (MI) platform delivered as a modular, all-in-one architecture. The core platform consists of five integrated modules: MI Inquiry Management with AI Co-Pilot (for omni-channel inquiry capture, routing and AI-assisted response), AI Content Creation and Lifecycle Management (for SRD generation and content versioning), Real-Time Analytics and Insights (for dashboards and trend analysis), Integrated Telephony (for call management within the platform), and Unified AE and PQC Intake Tool (for adverse event and product quality complaint handling). Customers can adopt a single module or scale to the full end-to-end platform. The product targets pharmaceutical brands (small-to-mid-size and large) and CROs, with built-in compliance safeguards and enterprise-grade security.

Product and service5 records
1MI Inquiry Management with AI Co-Pilot
CategoryMedical Information Inquiry Management
Description

Centralized module for capturing, triaging, and routing Medical Information (MI) inquiries across all channels with built-in AI assistance. Includes omni-channel intake forms, customizable routing, voice transcription, and an AI chatbot that surfaces approved-content responses. Designed for pharmaceutical brands and CROs that need end-to-end, auditable inquiry handling.

2AI Content Creation and Lifecycle Management
CategoryMedical Content Management
Description

Module for generating, managing, and controlling MI content throughout its lifecycle. Provides AI-powered summaries, compliant SRD creation, a version-controlled repository, approval workflows, multilingual templates, and AI-driven content tagging for reusability. Designed for MI teams that need faster, compliant content authoring with full version history.

3Real-Time Analytics and Insights
CategoryMI Analytics and Reporting
Description

Dashboard and analytics module providing live MI visibility, AI-driven trend analysis, and operational insights. Includes 360-degree audit readiness from compliance tracking to reporting, with AI-powered data analysis. Designed for MI leaders who need live dashboards and audit-ready reporting.

4Integrated Telephony
CategoryIntegrated Telephony
Description

Full-featured call center integrated directly into the MI platform. Includes IVR, call routing, recording, transcription, playback, voicemail, agent routing, after-hours flows, and automatic linking of call data to inquiry records. Designed for MI teams that need to eliminate standalone telephony and keep calls inside the MI workflow.

5Unified AE and PQC Intake Tool
CategoryAdverse Event and Product Quality Complaint Intake
Description

Module for unified capture, triage, and routing of Adverse Events (AE) and Product Quality Complaints (PQC) alongside MI inquiries. Features integrated safety and quality intake, AI autodetection of events, built-in QA, tamper-evident audit trails, and direct integration with safety database and quality management systems. Designed for pharma brands and CROs that need a single intake across MI, AE, and PQC.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Provides LifeSphere Safety, Quality, and related pharmacovigilance modules used by pharma for AE/PQC and MI workflows. Closely aligned with Nexentria's unified intake and compliance-focused value proposition for life sciences.

TypeBroad incumbent
Description

Largest global CRO with embedded technology and commercial/medical solutions serving pharma MI, safety, and commercial workflows. Comparable at the workflow level but as part of a much broader service and platform portfolio.

TypeRegional player
Description

Global medical communications and MI services provider under Ashfield (part of Inizio). Competes with Nexentria for MI workflows primarily via human services rather than SaaS, with strong relationships among large pharma.

TypeBroad incumbent
Description

Global CRO with significant medical information, safety, and pharmacovigilance services. Overlaps Nexentria's CRO customer segment and MI/AE/PQC workflows but delivered primarily as services rather than a modular SaaS platform.

TypeDirect peer
Description

Digital-first provider of commercial, medical affairs, and safety solutions specifically for life sciences. Directly comparable as a tech-enabled specialist operating in the same MI, content, and analytics workflows Nexentria targets.

TypeBroad incumbent
Description

Enterprise CRM platform used in life sciences for MI and customer engagement workflows. Competes at the platform level for pharma MI teams but lacks Nexentria's domain-specific MI, AE, and PQC automation and compliance guardrails.

TypeDirect peer
Description

Dominant SaaS provider for pharma with Vault Medical CRM, Vault Safety, and Vault Quality suites that directly overlap Nexentria's MI, AE, and PQC workflows. Most comparable direct competitor given shared domain, regulatory depth, and enterprise pharma focus.

TypeBroad incumbent
Description

Enterprise customer service and engagement platform frequently integrated into pharma support operations. Overlaps at the CRM/ticketing layer but requires extensive customization to match pharma MI regulatory and content workflows.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nexentria

Pharmaceutical Medical Information Softwarenexentria.com

Nexentria sells a modular, AI-powered Medical Information management SaaS platform to pharmaceutical brands and CROs, unifying MI inquiry handling, adverse event and product quality complaint intake, generative AI content creation, analytics, and integrated telephony with built-in regulatory compliance.

What Nexentria does

Nexentria Inc. is a privately-held SaaS company founded in 2023 and headquartered in San Francisco that sells an AI-powered Medical Information (MI) management platform to pharmaceutical and life sciences organizations. The platform unifies MI inquiry handling, Adverse Event (AE) and Product Quality Complaint (PQC) intake, AI-assisted content creation, real-time analytics, and integrated telephony across five modular products that customers can adopt individually or as a full end-to-end suite. Core technical components include an AI Co-Pilot using natural language processing for inquiry triage and response drafting, a generative AI engine that produces compliant Standard Response Documents (SRDs) and summaries, a Compliance Co-Pilot that flags content risk before distribution, AI autodetection for safety and quality events, and integrated telephony with call recording and transcription. The product is built for omni-channel intake, version-controlled content lifecycle management, multilingual support, and 360-degree audit readiness, with claimed GDPR, ISO 9001, ISO 27001, and HIPAA compliance.

The company targets three primary customer segments: small-to-mid-size life science brands, large pharmaceutical brands, and Contract Research Organizations (CROs) serving multiple sponsors. Its go-to-market is an enterprise field sales motion with quote-based modular pricing, multi-year SaaS contracts, and a demo-driven conversion funnel; pricing is not publicly disclosed. Distribution is direct (no channel partners disclosed) and the platform is positioned to integrate with customers' existing CRM, pharmacovigilance, and regulatory systems. Only one customer is publicly named — Biomapas, a global CRO — and the platform is described as capable of scaling from 5 to 50,000 inquiries per week. The company is led by co-founders Vilius Fokas (CEO, formerly at Biomapas and Avon), Stavros Tsompanidis (CPO, formerly at BMS, BioNTech and Intercept Pharmaceuticals), and Maksim Yankovskiy (CTO, formerly at Siemens Medical Solutions, Acuson and Zettaset SafeNet/Thales). No funding rounds, revenue figures, or institutional investors are disclosed in the available source material.

Nexentria firmographics

Firmographics
Name
Nexentria
Legal name
Nexentria Inc.
Website
https://nexentria.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Short description
Nexentria sells a modular, AI-powered Medical Information management SaaS platform to pharmaceutical brands and CROs, unifying MI inquiry handling, adverse event and product quality complaint intake, generative AI content creation, analytics, and integrated telephony with built-in regulatory compliance.
Ownership category
akta.pro rank

Nexentria industry classification

Industry
Product category
Pharmaceutical Medical Information Software
NAICS
Software Publishers (5132), Software Publishers (513210)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAEAJ
Adherence, Reminders & Engagement Automation (Medication/Follow-up)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms
SECONDARYHDAAAGAJ
B2B SaaS & Enterprise Personalization (CRM, Sales, Support)
SECONDARYBPAFAFAI
Customer Engagement & Messaging (Email, SMS, Push, In-App)

Keywords

  • Medical information management
  • Pharmaceutical AI platform
  • Adverse event intake
  • Generative AI content
  • Integrated telephony solutions

Where Nexentria is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Nexentria business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. SaaS Subscription: Modular SaaS platform with subscription-based pricing. Customers can purchase individual modules (MI Inquiry Management, AI Content Creation, Real-Time Analytics, Integrated Telephony, Unified AE/PQC Intake) or the full platform. Flexible pricing allows starting with one module and scaling to all-in-one platform

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractModular pricing - start with single module or full platform

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Nexentria product offering

Product offering

Core offering

Nexentria sells a modular, AI-powered Medical Information (MI) SaaS platform for pharmaceutical brands and Contract Research Organizations (CROs). The platform combines an AI Co-Pilot, generative AI content creation, integrated telephony, unified AE/PQC intake, and real-time analytics to capture, triage and resolve medical information inquiries, adverse events, and product quality complaints at scale. Customers can license individual modules or scale to the full end-to-end platform under multi-year, quote-based enterprise agreements.

Product overview

Nexentria offers an AI-powered Medical Information (MI) platform delivered as a modular, all-in-one architecture. The core platform consists of five integrated modules: MI Inquiry Management with AI Co-Pilot (for omni-channel inquiry capture, routing and AI-assisted response), AI Content Creation and Lifecycle Management (for SRD generation and content versioning), Real-Time Analytics and Insights (for dashboards and trend analysis), Integrated Telephony (for call management within the platform), and Unified AE and PQC Intake Tool (for adverse event and product quality complaint handling). Customers can adopt a single module or scale to the full end-to-end platform. The product targets pharmaceutical brands (small-to-mid-size and large) and CROs, with built-in compliance safeguards and enterprise-grade security.

Differentiator

Problem solved

Functional benefit

Products and services

  • MI Inquiry Management with AI Co-Pilot Centralized module for capturing, triaging, and routing Medical Information (MI) inquiries across all channels with built-in AI assistance. Includes omni-channel intake forms, customizable routing, voice transcription, and an AI chatbot that surfaces approved-content responses. Designed for pharmaceutical brands and CROs that need end-to-end, auditable inquiry handling.
  • AI Content Creation and Lifecycle Management Module for generating, managing, and controlling MI content throughout its lifecycle. Provides AI-powered summaries, compliant SRD creation, a version-controlled repository, approval workflows, multilingual templates, and AI-driven content tagging for reusability. Designed for MI teams that need faster, compliant content authoring with full version history.
  • Real-Time Analytics and Insights Dashboard and analytics module providing live MI visibility, AI-driven trend analysis, and operational insights. Includes 360-degree audit readiness from compliance tracking to reporting, with AI-powered data analysis. Designed for MI leaders who need live dashboards and audit-ready reporting.
  • Integrated Telephony Full-featured call center integrated directly into the MI platform. Includes IVR, call routing, recording, transcription, playback, voicemail, agent routing, after-hours flows, and automatic linking of call data to inquiry records. Designed for MI teams that need to eliminate standalone telephony and keep calls inside the MI workflow.
  • Unified AE and PQC Intake Tool Module for unified capture, triage, and routing of Adverse Events (AE) and Product Quality Complaints (PQC) alongside MI inquiries. Features integrated safety and quality intake, AI autodetection of events, built-in QA, tamper-evident audit trails, and direct integration with safety database and quality management systems. Designed for pharma brands and CROs that need a single intake across MI, AE, and PQC.

Quantifiable outcome

  • 2x faster onboarding compared to industry standard
  • +1 more outcomes

Companies that use Nexentria

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Nexentria technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature8 records

Nexentria partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Nexentria competitors and assessment

Company assessment

Direct peers

  • ArisGlobal: Provides LifeSphere Safety, Quality, and related pharmacovigilance modules used by pharma for AE/PQC and MI workflows. Closely aligned with Nexentria's unified intake and compliance-focused value proposition for life sciences.
  • Indegene: Digital-first provider of commercial, medical affairs, and safety solutions specifically for life sciences. Directly comparable as a tech-enabled specialist operating in the same MI, content, and analytics workflows Nexentria targets.
  • Veeva Systems: Dominant SaaS provider for pharma with Vault Medical CRM, Vault Safety, and Vault Quality suites that directly overlap Nexentria's MI, AE, and PQC workflows. Most comparable direct competitor given shared domain, regulatory depth, and enterprise pharma focus.

Broad incumbents

  • IQVIA: Largest global CRO with embedded technology and commercial/medical solutions serving pharma MI, safety, and commercial workflows. Comparable at the workflow level but as part of a much broader service and platform portfolio.
  • Parexel: Global CRO with significant medical information, safety, and pharmacovigilance services. Overlaps Nexentria's CRO customer segment and MI/AE/PQC workflows but delivered primarily as services rather than a modular SaaS platform.
  • Salesforce (Health Cloud / Service Cloud): Enterprise CRM platform used in life sciences for MI and customer engagement workflows. Competes at the platform level for pharma MI teams but lacks Nexentria's domain-specific MI, AE, and PQC automation and compliance guardrails.
  • Microsoft (Dynamics 365 Customer Service): Enterprise customer service and engagement platform frequently integrated into pharma support operations. Overlaps at the CRM/ticketing layer but requires extensive customization to match pharma MI regulatory and content workflows.

Regional players

  • Ashfield MedComms: Global medical communications and MI services provider under Ashfield (part of Inizio). Competes with Nexentria for MI workflows primarily via human services rather than SaaS, with strong relationships among large pharma.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Nexentria social profiles

Digital presence

Nexentria compliance and trust

Trust signal

Compliance4 records

Nexentria financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nexentria leadership team

Management profile

Number of profiles

Profiles3 records

Nexentria funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nexentria M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nexentria

What does Nexentria do?

Nexentria sells a modular, AI-powered Medical Information (MI) SaaS platform for pharmaceutical brands and Contract Research Organizations (CROs). The platform combines an AI Co-Pilot, generative AI content creation, integrated telephony, unified AE/PQC intake, and real-time analytics to capture, triage and resolve medical information inquiries, adverse events, and product quality complaints at scale. Customers can license individual modules or scale to the full end-to-end platform under multi-year, quote-based enterprise agreements.

Is Nexentria a public or private company?

Nexentria is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Nexentria founded?

Nexentria was founded in 2023. It employs 11 to 50 people.

Where is Nexentria based?

Nexentria is headquartered in San Francisco, United States, in the North America region.

How does Nexentria make money?

One revenue line is on record: saaS Subscription.

Who are Nexentria's main competitors?

Direct peers on record are ArisGlobal, Indegene and Veeva Systems. Broad incumbents are IQVIA, Parexel, Salesforce (Health Cloud / Service Cloud) and Microsoft (Dynamics 365 Customer Service). Ashfield MedComms is listed as a regional player.

Does Nexentria have an API?

No public API is recorded for Nexentria.

What industry is Nexentria in?

Nexentria's product category is Pharmaceutical Medical Information Software. Its primary akta.pro industry code is HLACAEAJ, Adherence, Reminders & Engagement Automation (Medication/Follow-up), with a secondary code of HDAAAGAJ, B2B SaaS & Enterprise Personalization (CRM, Sales, Support). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales